Mepolizumab 100mg powder for solution for injection vials
- SNOMED code
31210311000001108- Active compound
- Mepolizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Mepolizumab
— 100 mg
based on ingredient substance
- Form & Route
- solutioninjection.subcutaneous
Powder for solution for injection, Subcutaneous - Controlled drug
- No Controlled Drug Status
Products
Nucala 100mg powder for solution for injection vials (GlaxoSmithKline UK Ltd)
Nucala 100mg powder for solution for injection vials
- SNOMED code
31191311000001100- Supplier
- GlaxoSmithKline UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- Not available
- Licensed route
- Subcutaneous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Nucala 100mg powder for solution for injection vials (GlaxoSmithKline UK Ltd) 1 vial31191411000001107 ref. pack |
Discontinued
Legal category: POM | 5000123114672End: 0505429000325305000123115457 | NHS Indicative Price £840 | • Personally Administered • Hospital |
| — |
Reference packs
Mepolizumab 100mg powder for solution for injection vials 1 vial
- SNOMED code
31191011000001103- Quantity and unit
- 1 vial
- Packs